Has Robin Albritton, MD received payments from drug or device companies?

Yes. Drug and device makers reported $635 in general payments to Robin Albritton, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robin Albritton, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robin Albritton, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robin Albritton, MD

General Practice · Marianna, FLNPI 1992900708

Payments from drug & device makers

$635in general payments, 2019–2025

Across 14 payments — averaging $45.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Dexcom, Inc.$146
Cardiovascular Systems Inc.$144
Inari Medical, Inc.$139
Abbott$125
Exact Sciences$46
AbbVie$34

What the payments were for

Food & beverage$635100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Dexcom, Inc.	6	$146
Cardiovascular Systems Inc.	1	$144
Inari Medical, Inc.	1	$139
Abbott	1	$125
Exact Sciences	3	$46
AbbVie(2 entities)	2	$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FLOWTRIEVER CATHETER, S$279
Peripheral Orbital Atherectomy System$144
JETI$125

How this compares

$635 in reported general payments places this provider in the 70th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida →

Medicare billing

Part B allowed, 2024

$250,012

Medicare patients

526

Services billed

3,065

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	336	$172,040
MounjaroTirzepatide	57	$74,867
JardianceEmpagliflozin	80	$72,525
OzempicSemaglutide	47	$67,099
TriumeqAbacavir/Dolutegravir/Lamivudi	11	$43,578
JanuviaSitagliptin Phosphate	47	$41,510
Breo ElliptaFluticasone/Vilanterol	59	$38,237
XareltoRivaroxaban	40	$30,428
LinzessLinaclotide	35	$27,410
TrulicityDulaglutide	30	$26,143
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	33	$25,280
EntrestoSacubitril/Valsartan	26	$18,808
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	89	$17,340
MyrbetriqMirabegron	19	$14,020
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	424	$13,947

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieLinzess	$34	$27,41035 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,901 general practice providers in Florida.

Other general practice in Marianna

Jose CardonaMiami$71M
Lawrence GalitzMiami Gardens$42.5M
Armando AcevedoMiami$15.2M
Jorge AmayaMiami$14.2M
Frank AlvarezHialeah$13.6M
Hector RodriguezMiami$12.8M
Eddie ArmasSouth Miami$12.4M
Idalia AcostaMiami$11.4M
Lilia Rodriguez AblesMiami$10.7M
Jorge Monroy AvellaOcoee$10.6M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →